Successful bridge to recovery with VAD implantation for anthracycline-induced cardiomyopathy

Journal of Artificial Organs

Volumn 14, Issue 3, 2011, Pages 249-252

  Kurihara, Chitaru ^a   Nishimura, Takashi ^a   Nawata, Kan ^a   Kinoshita, Osamu ^a   Hisagi, Motoyuki ^a   Motomura, Noboru ^a   Kyo, Shunei ^a   Ono, Minoru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anthracycline induced cardiomyopathy; Bridge to recovery; Ventricular assist devices

Indexed keywords

ANTHRACYCLINE; CARVEDILOL; CATECHOLAMINE; CYCLOPHOSPHAMIDE; DAUNORUBICIN; DOBUTAMINE; LOPRINONE; NORADRENALIN; PREDNISOLONE; RITUXIMAB; SPIRONOLACTONE; VINCRISTINE;

ADULT; AORTA VALVE REGURGITATION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CASE REPORT; DYSPNEA; ECHOCARDIOGRAPHY; FATIGUE; HEART ASSIST DEVICE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE BIOPSY; HEART REHABILITATION; HEART TRANSPLANTATION; HEART VENTRICLE SIZE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALE; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; OXYGEN CONSUMPTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TRICUSPID VALVE REGURGITATION; WEIGHT GAIN;

ANTHRACYCLINES; CARDIOMYOPATHIES; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MITRAL VALVE ANNULOPLASTY; TREATMENT OUTCOME;

EID: 80052853559     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-011-0567-7     Document Type: Article

References (15)

1. EA Lefrak J Pitha S Rosenheim JA Gottlieb 1973 A clinicopathologic analysis of adriamycin cardiotoxicity Cancer 32 302 314 4353012 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2 1:STN:280:DyaE3s3jtVWquw%3D%3D
2. C Praga G Beretta PL Vigo GR Lenaz C Pollini G Bonadonna R Canetta R Castellani E Villa CG Gallagher H von Melchner M Hayat P Ribaud G De Wasch W Mattsson R Heinz R Waldner K Kolaric R Buehner W Ten Bokkel-Huyninck NI Perevodchikova LA Manziuk HJ Senn AC Mayr 1979 Adriamycin cardiotoxicity: a survey of 1273 patients Cancer Treat Rep 63 827 834 455324 1:STN:280: DyaE1M3htFShug%3D%3D (Pubitemid 9248185)
3. BV Jensen T Skovsgaard SL Nielsen 2002 Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients Ann Oncol 13 699 709 12075737 10.1093/annonc/mdf132 1:STN:280:DC%2BD38zjtlWrsw%3D%3D (Pubitemid 34567375)
4. AL Ferreira LS Matsubara BB Matsubara 2008 Anthracycline-induced cardiotoxicity Cardiovasc Hematol Agents Med Chem 6 278 281 18855640 10.2174/187152508785909474 1:CAS:528:DC%2BD1cXhtlCntbjL
5. E Castells J Roca A Miralles N Manito D Ortiz J Gonzalez J Granados M Benito M Rabasa F S'braga J Toscano D Toral A López C Fontanillas 2009 Recovery of ventricular function with a left ventricular axial pump in a patient with end-stage toxic cardiomyopathy not a candidate for heart transplantation: first experience in Spain Transplant Proc 41 2237 2239 19715885 10.1016/j.transproceed.2009.06.029 1:STN:280:DC%2BD1MrovFGitA%3D%3D
6. M Freilich D Stub D Esmore J Negri R Salamonsen P Bergin A Leet M Richardson A Taylor J Woodard D Kaye F Rosenfeldt 2009 Recovery from anthracycline cardiomyopathy after long-term support with a continuous flow left ventricular assist device J Heart Lung Transplant 28 101 103 19134539 10.1016/j.healun.2008.10.002
7. T Nishimura S Kyo 2010 Triple-site pacing: a new supported therapy approach for bridge to recovery with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy J Artif Organs 13 54 57 20174955 10.1007/s10047-010-0494-z
8. T Nishimura S Kyo 2010 High-dose carvedilol therapy for mechanical circulatory assisted patients J Artif Organs 13 88 91 20364287 10.1007/s10047-010-0495-y 1:CAS:528:DC%2BC3cXnvVems78%3D
9. M Nishimura M Ogiwara M Ishikawa K Imanaka N Okamura M Kato H Asano T Katogi O Kohmoto K Matsumoto S Nishimura S Kyo 2005 Successful bridge to resynchronization therapy with a left ventricular assist system in a patient with idiopathic dilated cardiomyopathy J Artif Organs 8 210 213 16235039 10.1007/s10047-005-0304-1 (Pubitemid 41464680)
10. EJ Birks PD Tansley J Hardy RS George CT Bowles M Burke NR Banner A Khaghani MH Yacoub 2006 Left ventricular assist device and drug therapy for the reversal of heart failure N Engl J Med 355 1873 1884 17079761 10.1056/NEJMoa053063 1:CAS:528:DC%2BD28XhtFKjurfJ (Pubitemid 44664645)
11. O Hequet QH Le I Moullet E Pauli G Salles D Espinouse C Dumontet C Thieblemont P Arnaud D Antal F Bouafia B Coiffier 2004 Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults J Clin Oncol 22 1864 1871 15143078 10.1200/JCO.2004.06.033 1:STN:280:DC%2BD2c3ksVCmsw%3D%3D (Pubitemid 41095177)
12. SE Lipshultz SD Colan RD Gelber AR Perez-Atayde SE Sallan SP Sanders 1991 Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood N Engl J Med 324 808 815 1997853 10.1056/NEJM199103213241205 1:STN:280:DyaK3M7kvVKksQ%3D%3D
13. LJ Steinherz PG Steinherz CT Tan G Heller ML Murphy 1991 Cardiac toxicity 4 to 20 years after completing anthracycline therapy JAMA 266 1672 1677 1886191 10.1001/jama.266.12.1672 1:STN:280:DyaK3MzlvFequg%3D%3D
14. BN Bernaba JB Chan CK Lai MC Fishbein 2010 Pathology of late-onset anthracycline cardiomyopathy Cardiovasc Pathol 19 308 311 19747852 10.1016/j.carpath.2009.07.004 1:CAS:528:DC%2BC3cXhtFClsrjO
15. VJ Ferrans JR Clark J Zhang ZX Yu EH Herman 1997 Pathogenesis and prevention of doxorubicin cardiomyopathy Tsitologiia 39 928 937 9505340 1:STN:280:DyaK1c7ms1aguw%3D%3D